Reversibel neutropeni blev observeret efter daglig intravenøs eller subkutan dosering i 30 dage, men ikke efter enkeltdoser eller daglig dosering i 14 dage.
Reversible neutropenia was seen following daily intravenous or subcutaneous dosing for 30 days, but not following single doses or daily dosing for 14 days.